Compare VERA & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | ERO |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2021 | N/A |
| Metric | VERA | ERO |
|---|---|---|
| Price | $48.95 | $25.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $67.67 | $25.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 696.31 |
| EPS | N/A | ★ 1.33 |
| Revenue | N/A | ★ $588,229,000.00 |
| Revenue This Year | N/A | $68.14 |
| Revenue Next Year | N/A | $46.45 |
| P/E Ratio | ★ N/A | $18.98 |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $18.53 | $9.30 |
| 52 Week High | $50.16 | $26.77 |
| Indicator | VERA | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 79.73 | 60.82 |
| Support Level | $40.38 | $24.80 |
| Resistance Level | $51.19 | $26.65 |
| Average True Range (ATR) | 3.50 | 1.11 |
| MACD | 1.07 | -0.02 |
| Stochastic Oscillator | 89.95 | 50.47 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.